Severity of Scleritis and Episcleritis

doi:10.1016/S0161-6420(94)31325-X

Ophthalmology

Volume 101, Issue 2, February 1994, Pages 389-396

https://doi.org/10.1016/S0161-6420(94)31325-X Get rights and content

Purpose: Inflammation of the wall of the eyeball may extend to adjacent ocular tissues with blinding consequences and may be associated with potentially lethal systemic disorders. This study was undertaken to evaluate the ocular complications and systemic disease associations of the different types of scleritis and episcleritis.

Methods: Ocular complications and specific disease association were evaluated in 266 patients (358 eyes) with different types of scleritis (diffuse, nodular, necrotizing, scleromalacia perforans, and posterior) and episcleritis (simple and nodular).

Results: In patients with scleritis, decrease in vision occurred in 37%, anterior uveitis was present in 42%, peripheral ulcerative keratitis developed in 14%, glaucoma occurred in 13%, cataract formed in 17%, fundus abnormalities appeared in 6%, and specific disease association was uncovered in 57%. These findings were most commonly associated with necrotizing scleritis. In patients with episcleritis, decreased vision occurred in 2%, anterior uveitis was present in 11%, glaucoma developed in 4%, cataract formed in 2%, and specific disease association was uncovered in 32%. These findings were similar in simple and nodular episcleritis.

Conclusions: In a patient with scleritis, examination of visual acuity, anterior uvea, cornea, lens, intraocular pressure, and fundus must be performed in every follow-up visit, and a meticulous approach for detection of a specific associated disease must be undertaken since the first visit. Scleritis is more severe than episcleritis, and necrotizing scleritis is the most severe type of scleritis. Classification of scleritis and episcleritis provides valuable prognostic information.

References (13)

LP Fong et al.
Immunopathology of scleritis
Ophthalmology
(1991)
CS Foster et al.
Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression
Ophthalmology
(1984)
CS Foster
Immunosuppressive therapy for external ocular inflammatory disease
Ophthalmology
(1980)
SJ Tuft et al.
Progression of scleral disease
Ophthalmology
(1991)
KN Hakin et al.
Systemic associations of scleritis
Int Ophthalmol Clin
(1991)
DDM McGavin et al.
Episcleritis and scleritis: a study of their clinical manifestations and association with rheumatoid arthritis
Br J Ophthalmol
(1976)

There are more references available in the full text version of this article.

Cited by (173)

Painful Eyes in Neurology Clinic: A Guide for Neurologists
2024, Neurologic Clinics
A bibliometric and visualized analysis of the pathogenesis of cataracts from 1999 to 2023
2024, Heliyon
Research on the pathogenesis of cataracts is ongoing and the number of publications on this topic is increasing annually. This study offers an overview of the research status, popular topics, and scholarly tendencies in the field of cataract pathogenesis over recent decades，which helps to guide future research directions, and optimize resource allocation. In the present study, we performed a bibliometric analysis of cataract pathogenesis. Publications from January 1, 1999, to December 20, 2023, were collected from the Web of Science Core Collection (WoSCC), and the extracted data were quantified and analyzed. We analyzed and presented the data using Microsoft Excel, VOSviewer, CiteSpace, and Python. In all, 4006 articles were evaluated based on various characteristics, including publication year, authors, countries, institutions, journals, citations, and keywords. This study utilized VOSviewer to conduct visualized analysis, including co-authorship, co-citation, co-occurrence, and network visualization. The CiteSpace software was used to identify keywords with significant bursts of activity. The number of annual global publications climbed from 76 to 277 between 1999 and 2023, a 264.47% rise. Experimental Eye Research published the most manuscripts (178 publications), whereas Investigative Ophthalmology & Visual Science received the most citations (6675 citations). The most influential and productive country, institution, and author were the United States (1244 publications, 54,456 citations), University of California system (136 publications, 5401 citations), and Yao Ke (49 publications, 838 citations), respectively. The top 100 ranked keywords are divided into four clusters through co-occurrence analysis: (1) secondary cataracts, (2) oxidative stress, (3) gene mutations and protein abnormalities, and (4) alteration of biological processes in lens epithelial cells. Further discussions on the four subtopics outline the research topics and trends. In conclusion, the specific mechanism of cataract formation remains a popular topic for future research and should be explored in greater depth.
Scleritis and episcleritis
2023, Revue de Medecine Interne
Les sclérites et épisclérites sont des maladies inflammatoires oculaires rares mais qui méritent d’être connues des internistes du fait de leur association fréquente à des maladies systémiques auto-immunes ou inflammatoires. Leur distinction par l’interrogatoire et l’examen ophtalmologique est importante car leur prise en charge, leur pronostic et leurs complications potentielles sont très différents. L’épisclérite représente une inflammation oculaire superficielle, de bon pronostic visuel avec un traitement souvent local, habituellement sans complication. Elle est très rarement associée à une maladie systémique auto-immune. En revanche, la sclérite est une atteinte ophtalmologique potentiellement grave qui peut menacer le pronostic visuel en l’absence de traitement systémique adapté. Elle est associée à une maladie sous-jacente dans 40 à 50 % des cas, en particulier une maladie systémique auto-immune (25 à 35 % des cas) ou une cause infectieuse (5 à 10 % des cas). La polyarthrite rhumatoïde et les vascularites systémiques, en particulier les vascularites associées aux anticorps anti-cytoplasme des polynucléaires neutrophiles (ANCA), sont les principales causes auto-immunes de sclérites et d’épisclérites. Les sclérites peuvent constituer une porte d’entrée révélatrice de la maladie auto-immune sous-jacente et imposent des explorations étiologiques systématiques. Elles nécessitent dans les formes agressives, compliquées, réfractaires ou associées à une maladie systémique auto-immune, le recours à une corticothérapie générale, voire un traitement immunosuppresseur, ainsi qu’une étroite collaboration entre ophtalmologues et internistes. L’avènement des biothérapies offre de nouveaux outils thérapeutiques efficaces dans la prise en charge de ces cas difficiles.
Scleritis and episcleritis are rare ocular inflammatory diseases but deserve to be known by internists because of their frequent association with systemic autoimmune diseases. It is important to distinguish them between because their prognosis, therapeutic management and potential complications are very different. Episcleritis represents a superficial ocular inflammation with usually benign visual prognosis, no complication with local treatment, and is associated with a systemic autoimmune disease in rare cases. In contrast, scleritis is a potentially serious ophthalmological condition that can threaten the visual prognosis in the absence of appropriate systemic treatment. It is associated with an underlying disease in 40–50% of cases, in particular a systemic autoimmune disease (25–35% of cases) or an infectious cause (5–10% of cases). Rheumatoid arthritis and systemic vasculitides, particularly antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides, are the main autoimmune causes of scleritis and episcleritis. Scleritis can reveal the underlying autoimmune disease and requires systematic etiological investigations. Aggressive, complicated, refractory forms or those associated with a systemic autoimmune disease require glucocorticoids or even immunosuppressants, and close collaboration between ophthalmologists and internists is required. The development of biologic agents offers new effective therapeutic tools in the management of these difficult cases.
Scleritis and sclerokeratitis associated with IgA vasculitis: A case series
2021, American Journal of Ophthalmology Case Reports
To describe a case series of scleritis associated with IgA vasculitis (IgAV) at a tertiary referral center.
Three men with scleritis associated with IgAV were identified: one with anterior scleritis alone, one with anterior scleritis and peripheral ulcerative keratitis (sclerokeratitis), and one with anterior and posterior scleritis. Visual acuity was preserved except from the patient who developed posterior scleritis. Ocular pain was the main symptom at presentation. All patients had a previous history of palpable purpura, but only one was aware of his underlying IgAV. Laboratory results revealed microhematuria and proteinuria with normal urinary β₂ microglobulin levels and negative serum ANCAs. Skin or kidney biopsy demonstrated leukocytoclastic vasculitis or glomerulonephritis with dominant IgA immune deposits.
Although uncommon, IgAV should be included in the differential diagnosis of anterior scleritis alone or associated with peripheral ulcerative keratitis or posterior scleritis, even in systemically asymptomatic patients. Urinalysis should not be underestimated in assessment of scleritis to detect early stages of glomerular disease. Scleritis may be the first manifestation whose study may lead to the diagnosis of IgAV. Multidisciplinary approach is necessary to prevent irreversible organ damage such as renal failure.
Mimickers of anterior uveitis, scleritis and misdiagnoses- tips and tricks for the cornea specialist
2024, Journal of Ophthalmic Inflammation and Infection
Unveiling Ocular Manifestations in Systemic Lupus Erythematosus
2024, Journal of Clinical Medicine

View all citing articles on Scopus

: Supported in part by MEC/Fulbright grant FU 90/37276861 and the Susan Morse Hilles Fund, Boston, Massachusetts.

View full text

Severity of Scleritis and Episcleritis

Ophthalmology

Ophthalmology

Ophthalmology

Ophthalmology

Systemic associations of scleritis

Int Ophthalmol Clin

Episcleritis and scleritis: a study of their clinical manifestations and association with rheumatoid arthritis

Br J Ophthalmol